Drug Topics Hospital Pharmacists' Report

June 28, 2012

Web Version  |   Unsubscribe  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

TOP STORY

ACA is upheld by U.S. Supreme Court

Today, the U.S. Supreme Court upheld the Affordable Care Act as constitutional, including its individual mandate requiring all Americans to purchase health insurance. In a 5-4 vote, the justices ruled that Congress has the right to impose the individual mandate under the taxing clause of the U.S. Constitution. » More

FDA approves weight-loss treatment

FDA has approved lorcaserin (Belviq, Arena Pharmaceuticals and Eisai) as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients who are overweight or obese and have at least one weight-related comorbid condition. It is the first prescription weight-loss treatment approved by FDA in 13 years. » More

Continuing Education

Psychopharmacology for the elderly

Late-life depression can occur in up to 50% of patients. Pharmacists can screen for unidentified cases and advocate for routine measurement of symptom severity.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

TODAY'S HEADLINES

Two pilot projects to test PDMPs

Healthcare providers and pharmacists will be able to identify and intervene in cases of potential prescription drug abuse through a new pilot program launched recently by the Department of Health and Human Services (HHS) Office of the National Coordinator for Health Information Technology, according to an HHS statement. » More

Combination therapy for youth with type 2 diabetes

A combination of 2 diabetes drugs, metformin and rosiglitazone (Avandia, GlaxoSmithKline), was more effective in treating youth with recent-onset type 2 diabetes than metformin alone, a study funded by the National Institutes of Health has found. » More

 

Subscribe Now!

You must click here to continue receiving the Drug Topics Hospital Pharmacists' Report

Check these out, too

CHADS2 scoring debate continues

Ifosfamide and nonmetastatic osteosarcoma

Certain EDCs linked to kids’ allergy risk

Study: Long-term efficacy of laropiprant

Voices

Anticoagulation Update

JP at Large: This is pharmacy?

View from the Zoo: The vertebral solution

Viewpoints: Guest columnists’ commentary

Regulatory and Legal: News, features, analysis

Meetings and Events

 
Powered by Modern Medicine Advanstar Medical Communications Group